{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:51:48Z","timestamp":1775587908121,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["DML"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The study was aimed at exploring the role of Acetyl L-Carnitine supplementation\nattenuating dementia and degradation of cognitive abilities in Hyperhomocysteinemia induced AD\nmanifestations in the mouse model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Alzheimer\u2019s disease (AD) is a neurological disorder that is marked by dementia, and\ndegradation of cognitive abilities. There is great popularity gained by natural supplements as the\ntreatment for AD, due to the higher toxicities of synthetic drugs. Hyperhomocysteinemia causes\nexcitotoxicity to the cortical neurons, which brought us to the point that amino acids possibly have\na role in causing cholinergic deformities, which are an important etiological parameter in AD.\nAcetyl L-Carnitine a methyl donor with the presence of three chemically reactive methyl groups\nlinked to a nitrogen atom was found to possess neuroprotective activity against experimental models\nof AD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of the present investigation was to investigate and evaluate the pharmacological\neffect of Acetyl L-Carnitine against hyperhomocysteinemia induced Alzheimer\u2019s disease\n(AD) in the mouse model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Material and Method:<\/jats:title>\n<jats:p>The animals were divided into normal control (vehicle-treated), HHcy\n(dl-Homocysteine thiolactone treated) negative control, test group i.e., low dose (50mg\/kg, p.o) of\nacetyl L-carnitine (L-ALC), high dose (100mg\/kg,p.o) of acetyl L-carnitine (H-ALC), L-ALC+\nSOV (Sodium orthovanadate) and H-ALC+SOV. HHcy was induced by administration of dl-Homocysteine\nthiolactone (dl-HCT; 1 g\/kg, p.o.) on day-1 to day-15 of experimental schedule to all\nanimals except normal control. The changes in the behaviour pattern of the animals due to neuroinflammation,\nand cholinergic dysfunction were examined in rotarod, novel objective recognition,\npassive avoidance, elevated plus maze, and morris water maze analysis. Biochemical investigation\nincludes the estimation of total homocysteine (tHcy), Creatinine Kinase (CK), Acetylcholinesterase\n(AChE), thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH) and IL-6\nand TNF-\u03b1.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Supplementation of ALC in mouse considerably lowered the HHcy-induced AD manifestations\nin the experimental animals. It was found that ALC and SOV successfully diminished the\nbehaviour abnormalities and lessened the Hcy-induced alteration in systemic Hcy levels, CK activity,\nand cholinergic dysfunction with improved bioenergetics in the Prefrontal cortex of the mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>ALC was found to improve the HHcy-induced cognitive disabilities which was found\nto be associated with the decreased systemic levels of Hcy, CK, and cholinergic abnormalities. It also\ncombats the oxidative stress-induced neuroinflammation with diminished pro-inflammatory\nmarkers in the pre frontal cortex. The outcomes collectively indicate ALC's potential to be used as\na supplementation in the pharmacotherapy of AD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1872312814666211209102136","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T05:37:38Z","timestamp":1639028258000},"page":"219-231","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating\nof Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive\nDeficit in Mouse Model"],"prefix":"10.2174","volume":"14","author":[{"given":"Nisha","family":"Verma","sequence":"first","affiliation":[{"name":"Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna Kumar","family":"Varshney","sequence":"additional","affiliation":[{"name":"MIT College of Pharmacy, MIT Campus, Moradabad, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Moradabad Educational Trust Group of\nInstitutions Faculty of Pharmacy, Moradabad, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Drug Metabolism Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/198691","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/198691\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/198691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T12:45:40Z","timestamp":1640954740000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/198691\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872312814666211209102136","relation":{},"ISSN":["1872-3128"],"issn-type":[{"value":"1872-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}